Rare Cause of Pelvic Mass: Hepatocellular Adenoma
-
Published:2024-06-01
Issue:1
Volume:8
Page:61-66
-
ISSN:2602-2397
-
Container-title:International Journal of Nature and Life Sciences
-
language:en
-
Short-container-title:Int J Nature Life Sci
Author:
Ünal Mücahit1ORCID, Balas Şener2ORCID
Affiliation:
1. Sakarya Yenikent Devlet Hastanesi 2. Dr. Abdurrahman Yurtaslan Oncology Research and Training Hospital
Abstract
Introduction: Hepatocellular adenoma (HA) is a rare solitary tumor originating from liver cells. There have been no reported cases with pelvic localization in the literature. In this article, we present a case of HA presenting with a pelvic mass.
Case: A 24-year-old male patient was found to have an intraabdominal mass on ultrasound during routine health screening. MRI (Magnetic Resonance Imaging) showed a solid mass lesion with pelvic localization, extending towards the upper abdomen, measuring approximately 16.5x8 cm, with sharp margins and well-defined borders, primarily suggestive of sarcomatous pathologies (rhabdomyosarcoma? / embryonal sarcoma?). Exploration revealed a mass resembling liver tissue attached to the left lobe of the liver via the falciform ligament, which was excised along with the ligament. The pathology of the specimen was consistent with adenoma. The patient was discharged on the third day postoperatively. Follow-up MRI at six months postoperatively did not reveal any issues.
Discussion and Conclusion: In patients with no significant etiological factors such as oral contraceptive use or anabolic androgen use, genetic studies and identification of possible environmental etiological factors from appropriate case series will contribute significantly to the literature. Our case demonstrated that even in male patients, HA should be considered in the differential diagnosis of intraabdominal masses.
Publisher
International Journal of Nature and Life Sciences
Reference17 articles.
1. Bacq, Y., Jacquemin, E., Balabaud, C., Jeannot, E., Scotto, B., Branchereau, S., Laurent, C., Bourlier, P., Pariente, D., de Muret, A., Fabre, M., Bioulac-Sage, P., & Zucman-Rossi, J. (2003). Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. Gastroenterology, 125 (5), 1470-1475. https://doi.org/10.1016/j.gastro.2003.07.012 2. Bala, S., Wünsch, P. H., & Ballhausen, W. G. (1997). Childhood hepatocellular adenoma in familial adenomatous polyposis: mutations in adenomatous polyposis coli gene and p53. Gastroenterology, 112 (3), 919-922. https://doi.org/10.1053/gast.1997.v112.pm9041254 3. Baum, J. K., Bookstein, J. J., Holtz, F., & Klein, E. W. (1973). Possible association between benign hepatomas and oral contraceptives. Lancet (London, England), 2 (7835), 926-929. https://doi.org/10.1016/s0140-6736(73)92594-4 4. Bieze, M., Phoa, S. S., Verheij, J., van Lienden, K. P., & van Gulik, T. M. (2014). Risk factors for bleeding in hepatocellular adenoma. The British Journal of Surgery, 10 1(7), 847-855. https://doi.org/10.1002/bjs.9493 5. Bioulac-Sage, P., Sempoux, C., & Balabaud, C. (2017). Hepatocellular adenoma: Classification, variants and clinical relevance. Seminars in Diagnostic Pathology, 34 (2), 112-125. https://doi.org/10.1053/j.semdp.2016.12.007
|
|